Skip to main content
. 2024 Apr 4;38:100764. doi: 10.1016/j.bbih.2024.100764

Table 1.

Demographic and clinical characteristics of healthy controls and patients with bipolar disorder per analysis. All categorical variables are presented as a percentage over the total number of participants. All continuous variables are presented with the median and the interquartile range. Abbreviations: BMI Body Mass Index; CMV Cytomegalovirus; IDS-C The Inventory of Depressive Symptomatology, Clinician Rating; YMRS Young Mania Rating Scale.

Healthy Controls Bipolar Disorder p-value
Staining A and B n = 113 n = 58
Female (%) 69.0% 50.0% 0.021
Age 38.5 (26.9, 50.4) 43.0 (35.0, 53.5) 0.12
BMI (kg/m2) 23.4 (20.7, 25.5) 25.0 (22.4, 28.1) 0.0032
CMV seropositive (%) 35.4% 39.7% 0.61
Anti-CMV titers (U/ml) 5.2 (3.7, 32.4) 5.0 (3.1, 45.7) 0.92
IDS-C 7.0 (4.0, 10.8)
YMRS 0.0 (0.0, 2.0)
Lithium treated %) 67.2%
Staining C n = 38 n = 50
Female (%) 60.5% 46.0% 0.31
Age 37.2 (27.9, 46.0) 44.2 (32.5, 55.5) 0.042
BMI (kg/m2) 22.4 (20.7, 25.0) 26.1 (22.8, 28.9) 0.0012
CMV seropositive (%) 44.7% 44.0% 11
Anti-CMV titers (U/ml) 5.6 (3.8, 36.6) 4.9 (3.5, 47.7) 0.72
IDS-C 6.0 (3.2, 9.8)
YMRS 0.0 (0.0, 2.0)
Lithium treated (%) 54.3%
Interleukin-7 analysis n = 167 n = 142
Female (%) 61.3%) 56.3% 0.41
Age 38.7 (26.8, 52.4) 45.5 (34.7, 55.0) 0.022
BMI (kg/m2) 23.6 (20.9, 25.7) 24.9 (22.5, 27.9) < 0.0012
CMV seropositive (%) 48.8% 38.4% 0.21
Anti-CMV titers (U/ml) 8.0 (3.8, 58.0) 4.7 (3.5, 45.7) 0.22
IDS-C 6.0 (4.0, 10.0)
YMRS 0.0 (0.0, 1.0)
Lithium treated (%) 58.1%
Interleukin-7 (pg/ml) 12.3 (9.3, 16.7) 10.8 (7.8, 13.7) < 0.0012